
Scientific Programme
The 20th Annual ENETS Conference
22 - 24 March 2023
Vienna, Austria

13th Annual ENETS Postgraduate Course
Wednesday, 22 March 2023
REGISTRATION & COFFEE
Time: Wednesday 08:00 - 08:45
Room: Entrance Hall
Welcome and opening - 20th Annual ENETS Conference
Time: Wednesday 08:45 - 08:50
Room: Hall E
Moderators:
Eva Tiensuu Janson, SWE
Opening & overview - 13th Annual ENETS Postgraduate Course
Time: Wednesday 08:50 - 09:00
Room: Hall E
Moderators:
Eric Baudin, FRA / Christos Toumpanakis, GBR
Session A: Diagnostic challenges & dilemmas in NEN medicine
Time: Wednesday 09:00 - 10:30
Room: Hall E
Moderators:
Beata Kos-Kudła, POL / John Ramage, GBR
09:00 - 09:06 | Are we sure that it is a NEN? The importance of histopathology review by a NEN expert pathologist
|
Aurel Perren, SUI |
09:06 - 09:10 | Discussion
|
Assessment of disease progression: “Tips and traps” | (09:10 - 09:40) |
09:10 - 09:16 | NET biomarkers: How do I interpret 5HIAA/Chromogranin A increase in small intestinal NET?
|
Staffan Welin, SWE |
09:16 - 09:20 | Discussion
|
09:20 - 09:32 | Imaging (cross-sectional and molecular): How do I interpret RECIST, non-RECIST progression, and PERCIST progression?
|
Clarisse Dromain, SUI / Anja Rinke, GER |
09:32 - 09:40 | Discussion
|
09:40 - 09:46 | FDG-avid lesion: Any robust implications to patients’ management?
|
Valentina Ambrosini, ITA |
09:46 - 09:50 | Discussion
|
09:50 - 09:56 | Should I re-biopsy during the course of the disease?
|
Martyn Caplin, GBR |
09:56 - 10:00 | Discussion
|
10:00 - 10:30 | Panel discussion
|
COFFEE BREAK
Time: Wednesday 10:30 - 11:00
Room: Entrance Hall
Session B: Therapeutic challenges and dilemmas in NEN medicine
Time: Wednesday 11:00 - 12:30
Room: Hall E
Moderators:
Els Nieveen van Dijkum, NED / Marianne Pavel, GER
11:00 - 11:10 | Optimal surgical approach to avoid short and long-term complications in localised small bowel and pancreatic NET
|
Detlef Bartsch, GER |
11:10 - 11:15 | Discussion
|
11:15 - 11:25 | Systemic NET treatments in populations with co-morbidities: What is different?
|
Nicola Fazio, ITA |
11:25 - 11:30 | Discussion
|
11:30 - 11:40 | Systemic treatments’ rechallenge: Is it really beneficial?
|
Enrique Grande, ESP |
11:40 - 11:45 | Discussion
|
11:45 - 11:55 | Is there any best sequence in localized NEC treatment?
|
Anna Koumarianou, GRE |
11:55 - 12:00 | Discussion
|
12:00 - 12:30 | Panel discussion
|
LUNCH BREAK
Time: Wednesday 12:30 - 14:00
Room: Entrance Hall
Session C: NET difficult scenarios
Time: Wednesday 14:00 - 15:30
Room: Hall E
Moderators:
Kjell Öberg, SWE / Anja Rinke, GER
14:00 - 14:10 | NET emergencies: Hormonal crises
|
Gregory Kaltsas, GRE |
14:10 - 14:15 | Discussion
|
14:15 - 14:25 | Mesenteric fibrosis: Best management of its complications
|
Hans Hofland, NED |
14:25 - 14:30 | Discussion
|
14:30 - 14:40 | NET bone metastases: Systemic management
|
Julien Hadoux, FRA |
14:40 - 14:45 | Discussion
|
14:45 - 14:55 | Nutrition support in advanced NETs
|
Dominique Clement, GBR |
14:55 - 15:00 | Discussion
|
15:00 - 15:30 | Panel discussion
|
COFFEE BREAK
Time: Wednesday 15:30 - 16:00
Room: Entrance Hall
Session D: Becoming familiar with new ENETS Guidance Papers through an MDT approach (Panel Discussion)
Time: Wednesday 16:00 - 17:30
Room: Hall E
Moderators:
Rocio Garcia-Carbonero, ESP / Christos Toumpanakis, GBR
MDT panel: Pathologist: Marie-Louise van Velthuysen, NED | NM Physician: Christophe Deroose, BEL | Surgeon: Ulrich Knigge, DEN | Gastroenterologist: Francesco Panzuto, ITA | Oncologist: Margot Tesselaar, NED | Endocrinologist: Beata Kos-Kudła, POL | NET Specialist Nurse: Wendy Martin, GBR
16:00 - 16:30 | Case 1: Metastatic small bowel NET with carcinoid syndrome and carcinoid heart disease
|
Christos Toumpanakis, GBR |
16:30 - 17:00 | Case 2: Functioning pNETs
|
Antongiulio Faggiano, ITA |
17:00 - 17:15 | Case 3: When right hemicolectomy is needed in appendiceal NET: Evolving data and controversies in management and follow-up
|
Gregory Kaltsas, GRE |
17:15 - 17:30 | Case 4: Small type III gastric NET treated by endoscopic resection
|
Francesco Panzuto, ITA |
Closing comments - 13th Annual ENETS Postgraduate Course
Time: Wednesday 17:30 - 17:40
Room: Hall E
Moderators:
Eric Baudin, FRA / Christos Toumpanakis, GBR
ENETS projects
Time: Wednesday 17:40 - 17:50
Room: Hall E
Moderators:
Eva Tiensuu Janson, SWE
Welcome reception
Time: Wednesday 18:00 - 19:00
Room: Entrance Hall
1st ENETS Basic and Translational NET Research – A Forum on Basic and Translational Science in Neuroendocrine Neoplasms
Wednesday, 22 March 2023
REGISTRATION & COFFEE
Time: Wednesday 08:00 - 08:45
Room: Entrance Hall
Welcome and opening - 20th Annual ENETS Conference (livestream from Hall E)
Time: Wednesday 08:45 - 08:50
Room: Hall F
Moderators:
Eva Tiensuu Janson, SWE
Welcome - 1st ENETS basic and translational NET research forum
Time: Wednesday 08:50 - 09:00
Room: Hall F
Moderators:
Justo P. Castaño, ESP / Anne Couvelard, FRA
Session 1
Time: Wednesday 09:00 - 10:30
Room: Hall F
Moderators:
Justo P. Castaño, ESP / Stefano La Rosa, ITA
09:00 - 09:25 | Single-nucleus and in situ RNA-sequencing reveal cell topographies in the human pancreas (Keynote speech)
|
Christian Conrad, GER |
09:25 - 09:30 | Discussion
|
09:30 - 09:45 | Recent molecular classifications of lung NENs: Where are we?
|
Lynnette Fernandez-Cuesta, FRA |
09:45 - 09:50 | Discussion
|
09:50 - 10:05 | The single-cell transcriptional landscape of lung carcinoid tumors
|
Philip Bischoff, GER |
10:05 - 10:10 | Discussion
|
10:10 - 10:17 | Abstract presentation: The lungNENomics project – A comprehensive multidisciplinary characterisation of pulmonary carcinoids
|
Matthieu Foll, FRA |
10:17 - 10:20 | Discussion
|
10:20 - 10:27 | Abstract presentation: Transcriptomic analyses of multifocal ileal neuroendocrine tumors
|
Netta Mäkinen, USA |
10:27 - 10:30 | Discussion
|
COFFEE BREAK
Time: Wednesday 10:30 - 11:00
Room: Entrance Hall
Session 2
Time: Wednesday 11:00 - 12:30
Room: Hall F
Moderators:
Anne Couvelard, FRA / Bertram Wiedenmann, GER
11:00 - 11:15 | Roles and mechanisms of alternative splicing in cancer - implications for care
|
Justo P. Castaño, ESP |
11:15 - 11:20 | Discussion
|
11:20 - 11:27 | Abstract presentation: Subtype-specific landscape of splicing-associated neoantigens and mutations in pancreatic neuroendocrine tumors
|
Anguraj Sadanandam, GBR |
11:27 - 11:30 | Discussion
|
11:30 - 11:45 | Cancer stem cells, immunotherapy and the importance of the microenvironment in pancreatic cancer and NENs
|
Bruno Sainz Anding, ESP |
11:45 - 11:50 | Discussion
|
11:50 - 11:57 | Abstract presentation: Molecular landscape of splicing dysregulation in pheochromocytomas and paragangliomas
|
María Trinidad Moreno-Montilla, ESP |
11:57 - 12:00 | Discussion
|
12:00 - 12:30 | Panel discussion
|
LUNCH BREAK
Time: Wednesday 12:30 - 14:00
Room: Entrance Hall
Session 3
Time: Wednesday 14:00 - 15:30
Room: Hall F
Moderators:
Joakim Crona, SWE / Guido Rindi, ITA
14:00 - 14:25 | A pan-tissue DNA methylation atlas enables in silico decomposition of human tissue methylomes at cell-type resolution (Keynote speech)
|
Chrissie Thirlwell, GBR |
14:25 - 14:40 | Epigenetics in NENs, role in oncogenesis and clinical potential
|
Ilaria Marinoni, SUI |
14:40 - 14:47 | Abstract presentation: The effect of pseudohypoxia on the immune microenvironment of pancreatic neuroendocrine neoplasms (PanNEN)
|
Amit Tirosh, ISR |
14:47 - 15:00 | Discussion
|
15:00 - 15:15 | Temozolomide and NETs: Friends or foes?
|
Jérôme Cros, FRA |
15:15 - 15:22 | Abstract presentation: Druggable growth dependencies and tumor evolution analysis in patient-derived organoids of neuroendocrine cancer
|
Talya Dayton, ESP |
15:22 - 15:30 | Discussion
|
COFFEE BREAK
Time: Wednesday 15:30 - 16:00
Room: Entrance Hall
Session 4
Time: Wednesday 16:00 - 17:30
Room: Hall F
Moderators:
Jaume Capdevila, ESP / Eva Tiensuu Janson, SWE
16:00 - 16:15 | The molecular landscape of high-grade gastroenteropancreatic NEN
|
Halfdan Sorbye, NOR |
16:15 - 16:20 | Discussion
|
16:20 - 16:27 | Abstract presentation: Germline whole-exome sequencing of patients with neuroendocrine neoplasms reveals pathogenic or likely pathogenic variants in a large subset of patients
|
Vineeth Sukrithan, USA |
16:27 - 16:30 | Discussion
|
16:30 - 16:45 | ALT-ered NENs: role and value of DAXX/TRX alterations to understand NEN pathology and disease prognosis
|
Rita Lawlor, ITA |
16:45 - 16:50 | Discussion
|
16:50 - 16:57 | Abstract presentation: Multi-omic factor analysis (MOFA) of well-differentiated neuroendocrine tumors (NETs) from different tumor sites
|
Carlos Carretero, ESP |
16:57 - 17:00 | Discussion
|
17:00 - 17:30 | Panel discussion
|
Closing comments - 1st ENETS basic and translational NET research forum
Time: Wednesday 17:30 - 17:40
Room: Hall F
Moderators:
Justo P. Castaño, ESP / Anne Couvelard, FRA
ENETS projects (livestream from hall E)
Time: Wednesday 17:40 - 17:50
Room: Hall F
Moderators:
Eva Tiensuu Janson, SWE
Welcome reception
Time: Wednesday 18:00 - 19:00
Room: Entrance Hall
20th Annual ENETS Conference
Thursday, 23 March 2023
Satellite Symposium - Industry-sponsored
Time: Thursday 07:45 - 08:45
Room: Hall F
Session 1: Interdisciplinary management of neuroendocrine tumor syndromes: Which tools for which goals ?
Time: Thursday 09:00 - 10:30
Room: Hall E
Moderators:
Francesco Panzuto, ITA / Staffan Welin, SWE
09:00 - 09:15 | Are functioning NET biologically distinct from non-functioning NET?
|
Eric Baudin, FRA |
09:15 - 09:20 | Discussion
|
09:20 - 09:35 | Carcinoid syndrome
|
Simona Glasberg, ISR |
09:35 - 09:40 | Discussion
|
09:40 - 09:55 | Ectopic Cushing syndrome
|
Camilla Schalin-Jantti, FIN |
09:55 - 10:00 | Discussion
|
10:00 - 10:15 | Other/rare functioning pancreatic NET
|
Wouter W. De Herder, NED |
10:15 - 10:20 | Discussion
|
10:20 - 10:27 | Abstract presentation: Glucagonomas – Characteristics and treatment options based on a French multicenter cohort study
|
Marine Perrier, FRA |
10:27 - 10:30 | Discussion
|
COFFEE BREAK
Time: Thursday 10:30 - 11:00
Room: Entrance Hall
Session 2A: Theragnostics
Time: Thursday 11:00 - 12:20
Room: Hall E
Moderators:
Christophe Deroose, BEL / Nicola Fazio, ITA
11:00 - 11:30 | Theragnostics (Keynote speech)
|
Andreas Kjaer, DEN |
11:30 - 11:37 | Abstract presentation: Tumor uptake on 18FDOPA PET/CT is a strong prognostic factor in patients with metastatic small intestine neuroendocrine tumors (siNETs) – A GTE study
|
Louis de Mestier, FRA |
11:37 - 11:40 | Discussion
|
11:40 - 11:47 | Abstract presentation: A novel and potent Pb-212 alpha-particle therapy for NETs – Complete responses in mouse models to global clinical translation for NET patients
|
Markus Puhlmann, USA |
11:47 - 11:50 | Discussion
|
11:50 - 11:57 | Abstract presentation: First report of the phase I LuPARP trial assessing 177Lu-DOTATATE in combination with the PARP inhibitor olaparib in patients with somatostatin positive tumors
|
Andreas Hallqvist, SWE |
11:57 - 12:00 | Discussion
|
12:00 - 12:07 | Abstract presentation: Intra-arterial PRRT – A prospective clinical study in NET patients with hepatic metastases
|
Sander Ebbers, NED |
12:07 - 12:10 | Discussion
|
12:10 - 12:17 | Abstract presentation: Imaging surveillance in multiple endocrine neoplasia type 1 – 10 years of experience with somatostatin receptor positron emission tomography
|
Mikkel Andreassen, DEN |
12:17 - 12:20 | Discussion
|
Session 2B: INCA/ENETS Symposium: Working together to improve patient outcomes
Time: Thursday 11:00 - 12:00
Room: Hall F
Moderators:
Mark McDonnell, IRL / Eva Tiensuu Janson, SWE
11:00 - 11:02 | Welcome and introductions from ENETS/INCA
|
Mark McDonnell, IRL / Eva Tiensuu Janson, SWE |
11:02 - 11:14 | Educating the Non-NEN physicians: ‘Think NENs’ educational program for GPs
|
Sugandha Dureja, IND / Dermot O'Toole, IRL |
11:14 - 11:29 | The optimal NEN patient pathway – From Aspiration to reality
|
Catherine Bouvier Ellis, GBR / Rocio Garcia-Carbonero, ESP / Teodora Kolarova, BUL |
11:29 - 11:42 | The instrumental role of patient input in research design
|
Stephanie Alband, USA / Simron Singh, CAN |
11:42 - 11:57 | Q & A
|
11:57 - 12:00 | Wrap-up and close
|
Mark McDonnell, IRL / Eva Tiensuu Janson, SWE |
LUNCH BREAK
Time: Thursday 12:30 - 14:00
Room: Entrance Hall
Satellite Symposium - Industry-sponsored
Time: Thursday 12:30 - 14:00
Room: Hall F
Session 3A: Joint ENETS-ESR Session
Time: Thursday 14:00 - 15:10
Room: Hall E
Moderators:
Clarisse Dromain, SUI / Marius Mayerhoefer, USA
14:00 - 14:25 | Limitations of RECIST for neuroendocrine therapy monitoring
|
Damiano Caruso, ITA |
14:25 - 14:50 | Tumor Growth Rate (TGR) for neuroendocrine therapy monitoring
|
Angela Lamarca, ESP |
14:50 - 15:10 | Panel discussion
|
Session 3B: Clinical abstract session
Time: Thursday 14:00 - 15:00
Room: Hall F
Moderators:
Rocio Garcia-Carbonero, ESP / Eva Tiensuu Janson, SWE
14:00 - 14:07 | OTP, CD44, and Ki-67 – A prognostic marker panel for relapse free survival in patients with surgically resected pulmonary carcinoid
|
Laura Moonen, NED |
14:07 - 14:10 | Discussion
|
14:10 - 14:17 | Cabozantinib in high grade neuroendocrine neoplasms – Interim results from a Phase II trial
|
Nikolaos Trikalinos, USA |
14:17 - 14:20 | Discussion
|
14:20 - 14:27 | Subgroup analysis of ORR and PFS of the SEQTOR study (GETNE 1206) – Everolimus followed by Streptozotocin (STZ)-5FU upon progression or the reverse sequence, in advanced progressive panNETs
|
Jaume Capdevila, ESP |
14:27 - 14:30 | Discussion
|
14:30 - 14:37 | Long-term outcomes of surgical valve replacement in patients with severe carcinoid heart disease
|
Aimee Hayes, GBR |
14:37 - 14:40 | Discussion
|
14:40 - 14:47 | Treatment efficacy in 212 metastatic small intestinal neuroendocrine tumor grade 2 patients
|
Dimitrios Papantoniou, SWE |
14:47 - 14:50 | Discussion
|
14:50 - 14:57 | Clinical and morphogenetic features of renal neuroendocrine tumors
|
Atsuko Kasajima, GER |
14:57 - 15:00 | Discussion
|
Life Achievement Award
Time: Thursday 15:10 - 15:30
Room: Hall E
Moderators:
Eva Tiensuu Janson, SWE
15:10 - 15:20 | Laudatio
|
Frediano Inzani, ITA |
15:20 - 15:30 | Recipient and keynote address
|
Guido Rindi, ITA |
COFFEE BREAK
Time: Thursday 15:30 - 16:00
Room: Entrance Hall
Session 4A: Mixed neuroendocrine – non-neuroendocrine neoplasms
Time: Thursday 16:00 - 17:10
Room: Hall E
Moderators:
Halfdan Sorbye, NOR / Marie-Louise van Velthuysen, NED
16:00 - 16:15 | Mixed NE- non-NE neoplasms in different organs: Definitions, concepts, and challenges
|
Stefano La Rosa, ITA |
16:15 - 16:20 | Discussion
|
16:20 - 16:35 | How to treat mixed NEN?
|
Francesca Spada, ITA |
16:35 - 16:40 | Discussion
|
16:40 - 16:55 | A clinico-pathological case of digestive MiNEN
|
Melissa Frizziero, GBR |
16:55 - 17:10 | Panel discussion
|
Session 4B: Nutritional aspects of NET
Time: Thursday 17:10 - 17:30
Room: Hall E
Moderators:
Halfdan Sorbye, NOR / Marie-Louise van Velthuysen, NED
17:10 - 17:17 | Abstract presentation: Nutritional status of patients with advanced gastroenteropancreatic (GEP) neuroendocrine neoplasms (NENs) in Spain – NUTRIGETNE study
|
Maribel Del Olmo Garcia, ESP |
17:17 - 17:20 | Discussion
|
17:20 - 17:27 | Abstract presentation: Real-world data regarding the obesity paradox in patients with gastroenteropancreatic (GEP) NENs in a single centre in the United Kingdom
|
Dominique Clement, GBR |
17:27 - 17:30 | Discussion
|
Session 4C: Bronchial and thymic NET
Time: Thursday 16:00 - 17:30
Room: Hall F
Moderators:
Eric Baudin, FRA / Anne-Marie Dingemans, NED
16:00 - 16:10 | Biology of bronchial and thymic carcinoids: What is clinically relevant?
|
Anne-Marie Dingemans, NED |
16:10 - 16:15 | Discussion
|
16:15 - 16:25 | How to perform an RO resection in bronchial and thymic carcinoids?
|
Pier Luigi Filosso, ITA |
16:25 - 16:30 | Discussion
|
16:30 - 16:40 | Locoregional management: When and how? (Focus on lung, pleura, and bone)
|
Frederic Deschamps, FRA |
16:40 - 16:45 | Discussion
|
16:45 - 16:55 | Updates in the management of advanced bronchial and thymic carcinoids
|
Jaume Capdevila, ESP |
16:55 - 17:00 | Discussion
|
17:00 - 17:07 | Abstract presentation: Protein validation of multi-omic classified pulmonary carcinoid – Identification of unique clinical subtypes and potential therapeutic vulnerability
|
Jules Derks, NED |
17:07 - 17:10 | Discussion
|
17:00 - 17:07 | Abstract presentation: Surgery of primary lung carcinoid tumors at metastatic stage – A national study from the French Group of Endocrine Tumors (GTE) and ENDOCAN-RENATEN network
|
Thomas Walter, FRA |
17:17 - 17:20 | Discussion
|
17:00 - 17:07 | Abstract presentation: R-ache-L score – A nomogram model for predicting prognosis of lung neuroendocrine tumors according to primary tumor side
|
Anna La Salvia, ITA |
17:27 - 17:30 | Discussion
|
Satellite Symposium - Industry-sponsored
Time: Thursday 17:45 - 19:15
Room: Hall F
Friday, 24 March 2023
Session 5A: New developments in systemic therapy of NEN
Time: Friday 09:00 - 10:30
Room: Hall E
Moderators:
Marianne Pavel, GER / Philippe Ruszniewski, FRA
09:00 - 09:15 | Where is the place of angiogenesis inhibitors in the treatment algorithm of NEN?
|
Marianne Pavel, GER |
09:15 - 09:20 | Discussion
|
09:20 - 09:35 | New avenues for immunotherapy: Combinations and beyond…
|
Daniel M. Halperin, USA |
09:35 - 09:50 | Can systemic therapy improve PRRT efficacy?
|
Damian Wild, SUI |
09:50 - 10:05 | New targets and potential agents directed to NEN therapy
|
Christoph J. Auernhammer, GER |
10:05 - 10:20 | Panel discussion
|
10:20 - 10:27 | Abstract presentation: Phase II study of pembrolizumab and lenvatinib in advanced well-differentiated neuroendocrine tumors
|
Jonathan Strosberg, USA |
10:27 - 10:30 | Discussion
|
Session 5B: Nurses & Dietitians Symposium
Time: Friday 09:00 - 10:00
Room: Hall F
Moderators:
Yasmin Chotai de Lima, GBR / Wanda Geilvoet, NED
09:00 - 09:05 | Welcome and update on nurses and dietitian group
|
Wendy Martin, GBR |
09:05 - 09:20 | Assessing the nutritional status of patients with NEN’s
|
Erin Laing, AUS |
09:20 - 09:35 | Sarcopenia in patients with NEN’s
|
Dominique Clement, GBR |
09:35 - 09:55 | Case study – Managing a patient with complex nutritional needs (interactive session)
|
Mette Borre, DEN / Deborah Pitfield, GBR |
Panel: Erin Laing, AUS / Dominique Clement, GBR / Wendy Martin, GBR
09:55 - 10:00 | Thank you and closing comments
|
Wendy Martin, GBR |
Session 5C: Clinical abstracts
Time: Friday 10:00 - 10:30
Room: Hall F
Moderators:
Hans Hofland, NED / Nicholas Reed, GBR
10:00 - 10:07 | Are hemicolectomies still indicated in patients with neuroendocrine tumours of the appendix 1-2cm? A retrospective Europe-wide cohort study
|
Cédric Nesti, SUI |
10:07 - 10:10 | Discussion
|
10:10 - 10:17 | No multiple endocrine neoplasia type 1 (MEN1) Patient died from pancreaticoduodenal neuroendocrine tumor – Results from long-term follow-up of the Uppsala model of early diagnosis and treatment
|
Duska Bajic, SWE |
10:17 - 10:20 | Discussion
|
10:20 - 10:27 | Endoscopic ultrasound-guided radiofrequency ablation versus surgical resection for the treatment of pancreatic insulinoma – A multicenter propensity score-matched study
|
Stefano Francesco Crinò, ITA |
10:27 - 10:30 | Discussion
|
COFFEE BREAK
Time: Friday 10:30 - 11:00
Room: Entrance Hall
Session 6A: Colorectal NET
Time: Friday 11:00 - 12:10
Room: Hall E
Moderators:
John Ramage, GBR / Thomas Walter, FRA
11:00 - 11:10 | Epidemiology and health economics: Comparison of incidences around the world
|
Côme Lepage, FRA |
11:10 - 11:15 | Discussion
|
11:15 - 11:30 | Colo-rectal NET: Surgery vs endoscopy
|
Els Nieveen van Dijkum, NED |
11:30 - 11:35 | Discussion
|
11:35 - 11:45 | What to do after R1 endoscopic rectal resection?
|
Raj Srirajaskanthan, GBR |
11:45 - 11:50 | Discussion
|
11:50 - 11:57 | Abstract presentation: Outcome of endoscopic submucosal dissection for rectal neuroendocrine neoplasms – A multicentre study
|
Alessandro Rimondi, ITA |
11:57 - 12:00 | Discussion
|
12:00 - 12:07 | Abstract presentation: Heterogeneity and potential therapeutic targets of rectal neuroendocrine tumors by single cell RNA-sequencing combined with spatial omics
|
Qiyun Tang, CHN |
12:07 - 12:10 | Discussion
|
Session 6B: Basic and translational science abstracts
Time: Friday 11:00 - 12:10
Room: Hall F
Moderators:
Aurel Perren, SUI / Chrissie Thirlwell, GBR
11:00 - 11:07 | Wide molecular analysis of PanNET revealed that only MGMT promoter methylation seemed to correlate with Temozolomide response
|
Ilaria Marinoni, SUI |
11:07 - 11:11 | Discussion
|
11:11 - 11:18 | Germline pathogenic variants in patients with high-grade gastroenteropancreatic neuroendocrine neoplasms
|
Halfdan Sorbye, NOR |
11:18 - 11:23 | Discussion
|
11:23 - 11:31 | Predictive transcriptomic signature of response to axitinib in patients with advanced NETs included in the randomized, double-blind, placebo-controlled AXINET trial (GETNE 1107)
|
Alberto Lens-Pardo, ESP |
11:31 - 11:35 | Discussion
|
11:35 - 11:42 | Determining the resistance to somatostatin analogues in pheochromocytomas and paragangliomas
|
Víctor García Vioque, ESP |
11:42 - 11:47 | Discussion
|
11:47 - 11:54 | Mesenteric fibrosis in small intestinal neuroendocrine tumours (SI-NETs) – Steps towards understanding its pathogenesis
|
Harry Hodgetts, GBR |
11:54 - 11:58 | Discussion
|
11:58 - 12:05 | Autologous ECM-composed scaffolds and zebrafish PDXs for individualized therangostics in rare neuroendocrine neoplasms
|
Chiara Liverani, ITA |
12:05 - 12:10 | Discussion
|
LUNCH BREAK
Time: Friday 12:10 - 12:55
Room: Entrance Hall
Session 7: Abstracts and research highlights in 2022
Time: Friday 12:55 - 13:50
Room: Hall E
Moderators:
Eva Tiensuu Janson, SWE
12:55 - 13:25 | Medical review
|
Nicholas Reed, GBR |
13:25 - 13:50 | Surgical review
|
Stefano Partelli, ITA |
Awards Ceremony
Time: Friday 13:50 - 14:25
Room: Hall E
Closing comments
Time: Friday 14:25 - 14:30
Room: Hall E
Moderators:
Eva Tiensuu Janson, SWE